GMP (Good Manufacturing Practice) Annex 1: Compliant Aseptic Operations Training Course (May 19th - May 21st, 2026)" training has been added to ResearchAndMarkets.com's offering. In August 2022, (14 ...

Frontage Laboratories, Inc., a leading contract development and manufacturing organization (CDMO) announced that its new ...

The Nanoparticle Contract Manufacturing market offers opportunities in pharmaceuticals, biotech, and advanced materials, ...

According to MarketsandMarkets™, the Pharmaceutical Microfiltration Market is projected to grow from about USD 6.13 billion ...

Global Pharmaceutical Manufacturing Equipment Market OverviewThe global pharmaceutical manufacturing equipment market is on a growth trajectory, projected to expand at a CAGR of 6–8% over the forecast ...

Across FY26–28, Jefferies forecasts double-digit revenue growth for the sector, led by Biocon (14%), boosted by upcoming ...

This is the first article of our series, “The ATMP Manufacturer’s Guide to Commercialisation and cGMP Compliance”. The shift from R&D to the regulated cGMP facility is often a difficult gap to bridge, ...

Cipla had earlier received final USFDA approval in May 2024 to market its generic Lanreotide injection in multiple strengths.

BRISBANE, Australia and CAMBRIDGE, Mass., Jan. 07, 2026 (GLOBE NEWSWIRE) -- Vaxxas Pty Ltd today announced the appointment of global biopharmaceutical executive Mr David Peacock as Chief Executive ...

FORT LAUDERDALE, Fla., Jan. 6, 2026 /PRNewswire/ -- GBI Biomanufacturing, a U.S.-based biopharmaceutical CDMO providing integrated development and cGMP manufacturing services for complex biologics, ...

According to MarketsandMarkets, the Pharmaceutical Microfiltration Market is projected to grow from about USD 6.13 billion in 2025 to USD 9.94 ...

Vaxxas has appointed former Merck Global Vaccines president David Peacock as chief executive officer (CEO), marking a step in ...